Huntington National Bank / LLY
Huntington National Bank’s Eli Lilly & Co Position
Does Huntington National Bank own Eli Lilly & Co (LLY)? Yes — 260.7K shares worth $240M (+1.32% of its 13F portfolio) as of Q1 2026, up from 258.0K shares the prior filed quarter.
Position Value
$240M
Q1 2026
Shares
260.7K
% of Portfolio
+1.32%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 260.7K | $240M | +1.32% |
| Q4 2025 | 258.0K | $277M | +1.66% |
| Q3 2025 | 262.1K | $200M | +1.22% |
| Q2 2025 | 271.5K | $212M | +1.39% |
| Q1 2025 | 279.6K | $231M | +1.67% |
| Q4 2024 | 286.3K | $221M | +1.58% |
| Q3 2024 | 297.4K | $264M | +1.92% |
| Q2 2024 | 296.9K | $269M | +2.08% |
| Q1 2024 | 305.7K | $238M | +1.91% |
| Q4 2023 | 302.2K | $176M | +1.60% |
| Q3 2023 | 307.5K | $165M | +1.66% |
| Q2 2023 | 316.9K | $149M | +1.38% |
| Q1 2023 | 280.4K | $96M | +0.96% |
| Q4 2022 | 282.6K | $103M | +1.08% |
| Q3 2022 | 281.7K | $91M | +1.04% |
| Q2 2022 | 281.3K | $91M | +0.98% |
| Q1 2022 | 271.6K | $78M | +0.72% |
| Q4 2021 | 254.5K | $70M | +0.64% |
| Q3 2021 | 241.4K | $56M | +0.56% |
| Q2 2021 | 238.6K | $55M | +0.55% |
| Q1 2021 | 226.8K | $42M | +0.51% |
| Q4 2020 | 217.0K | $37M | +0.48% |
| Q3 2020 | 213.6K | $32M | +0.46% |
| Q2 2020 | 204.8K | $34M | +0.53% |
| Q1 2020 | 157.7K | $22M | +0.41% |
| Q4 2019 | 100.6K | $13M | +0.20% |
| Q3 2019 | 105.0K | $12M | +0.19% |
| Q2 2019 | 108.4K | $12M | +0.19% |
| Q1 2019 | 108.2K | $14M | +0.23% |
| Q4 2018 | 111.8K | $13M | +0.23% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Huntington National Bank’s full portfolio or all institutional holders of LLY.